Arcadia Biosciences (RKDA) Downgraded by Zacks Investment Research

Arcadia Biosciences (NASDAQ:RKDA) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a report released on Wednesday.

According to Zacks, “Arcadia Biosciences, Inc. is engaged in developing and commercializing agricultural products primarily in the United States. The Company’s product includes nitrogen use crops, salt tolerant plants, sunflower oil and shelf-life produce. Arcadia Biosciences, Inc. is headquartered in Davis, California. “

Several other equities research analysts have also weighed in on RKDA. ValuEngine upgraded shares of Arcadia Biosciences from a “sell” rating to a “hold” rating in a report on Wednesday, October 17th. HC Wainwright set a $20.00 target price on shares of Arcadia Biosciences and gave the stock a “buy” rating in a report on Thursday, December 13th.

RKDA opened at $4.39 on Wednesday. The firm has a market capitalization of $19.87 million, a price-to-earnings ratio of -0.64 and a beta of -2.53. Arcadia Biosciences has a twelve month low of $2.64 and a twelve month high of $66.56.

Large investors have recently modified their holdings of the stock. Vanguard Group Inc acquired a new stake in shares of Arcadia Biosciences during the third quarter worth $91,000. Dimensional Fund Advisors LP acquired a new stake in shares of Arcadia Biosciences during the third quarter worth $112,000. Finally, Virtu Financial LLC acquired a new stake in shares of Arcadia Biosciences during the third quarter worth $121,000. Institutional investors and hedge funds own 8.88% of the company’s stock.

About Arcadia Biosciences

Arcadia Biosciences, Inc, an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits.

Featured Article: What is a Roth IRA?

Get a free copy of the Zacks research report on Arcadia Biosciences (RKDA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit